Health
Results: 4777-4788 of 9325

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

Broken String Biosciences Launches Catalyst Program to Shorten Gene Editing Therapy Development by Months

Stax Appoints Adam Thorpe as Managing Director to Lead EMEA Healthcare Vertical and Drive Expansion in UK and European Markets

Accord Healthcare: Hetronifly® (Serplulimab) receives Marketing Authorisation from the European Commission (EC), for the treatment of Extensive-Stage Small Cell Lung Cancer (ES- SCLC)




